scispace - formally typeset
F

Fosca Quarti Trevano

Researcher at University of Milano-Bicocca

Publications -  34
Citations -  2179

Fosca Quarti Trevano is an academic researcher from University of Milano-Bicocca. The author has contributed to research in topics: Blood pressure & Ambulatory blood pressure. The author has an hindex of 16, co-authored 33 publications receiving 1961 citations. Previous affiliations of Fosca Quarti Trevano include University of Milan.

Papers
More filters
Journal ArticleDOI

Long-Term Prognostic Value of Blood Pressure Variability in the General Population. Results of the Pressioni Arteriose Monitorate e Loro Associazioni Study

TL;DR: The data show that the relationship of blood pressure to prognosis is complex and that phenomena other than 24-hour mean values are involved, and provide the first evidence that short-term erratic components of blood Pressure variability play a prognostic role.
Journal ArticleDOI

Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives.

TL;DR: CO is characterized by a sympathetic activation greater for magnitude than that detectable in PO, which appears not to be related to gender or to baroreflex mechanisms but rather to metabolic factors, i.e. to the greater insulin resistance characterizing CO.
Journal ArticleDOI

Metabolic Syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) Study: Daily Life Blood Pressure, Cardiac Damage, and Prognosis

TL;DR: The prevalence of metabolic syndrome and its relationship with daily life blood pressure, cardiac damage, and prognosis were determined in 2013 subjects from a Northern Italian population aged 25 to 74 years as discussed by the authors.
Journal ArticleDOI

Obstructive Sleep Apnea–Dependent and –Independent Adrenergic Activation in Obesity

TL;DR: The data demonstrate that the sympathetic activation of obesity occurs independently in obstructive sleep apnea, and show that this condition exerts sympathostimulating effects independent of body weight, and that the obstructiveSleep apnea–dependent and –independent sympathostIMulation contribute to the overall adrenergic activation of the obese state.
Journal ArticleDOI

Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study.

TL;DR: Evidence is provided that, in obese hypertensive individuals, treatment with candesartan cilexetil has an antihypertensive effect similar to that of HCTZ, which improves insulin sensitivity and exerts sympathoinhibitory effects.